Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Carvedilol
Drug ID BADD_D00374
Description Carvedilol is a racemic mixture where the S(-) enantiomer is a beta adrenoceptor blocker and the R(+) enantiomer is both a beta and alpha-1 adrenoceptor blocker.[L7889,L7892] It is currently used to treat heart failure, left ventricular dysfunction, and hypertension.[L7889,L7892] The dual action of carvedilol is advantageous in combination therapies as moderate doses of 2 drugs have a decreased incidence of adverse effects compared to high dose monotherapy in the treatment of moderate hypertension.[A182306] Carvedilol was granted FDA approval on 14 September 1995.[L7889]
Indications and Usage For the treatment of mild or moderate (NYHA class II or III) heart failure of ischemic or cardiomyopathic origin.
Marketing Status Prescription; Discontinued
ATC Code C07AG02
DrugBank ID DB01136
KEGG ID D00255
MeSH ID D000077261
PubChem ID 2585
TTD Drug ID D0W9LX
NDC Product Code 71335-0368; 65862-142; 64220-150; 0615-8390; 50090-1856; 65691-0087; 61919-984; 68462-162; 43353-838; 63187-570; 68462-164; 68001-152; 0781-5222; 68001-154; 65862-145; 43063-125; 63187-409; 60760-234; 71335-1545; 71335-1407; 43353-874; 50090-2175; 71610-067; 68382-092; 68071-4470; 63187-424; 53104-7575; 51079-930; 61919-730; 65862-144; 70934-517; 68788-9789; 65841-617; 68071-3151; 70518-2389; 71335-0034; 70518-1377; 68071-4495; 35356-526; 61919-728; 63629-4070; 0615-8388; 42419-013; 68645-350; 72761-004; 55154-6883; 43353-837; 70934-406; 70518-0582; 0904-6300; 55154-5678; 72888-037; 68462-165; 51407-041; 0615-8387; 50090-1064; 55154-7278; 68071-4956; 70934-759; 70518-0356; 71610-066; 0904-6301; 63187-941; 43063-126; 50090-4898; 51655-397; 0093-7295; 68382-095; 70934-707; 51655-033; 65862-143; 51079-771; 51079-931; 61919-219; 55111-252; 68645-351; 70934-609; 68294-0005; 53002-1572; 60760-494; 76385-113; 50090-1069; 71335-1813; 68788-8151; 65841-618; 68001-151; 55111-255; 51407-039; 71335-2023; 57451-1155; 0904-6302; 0378-3633; 55154-6885; 60760-532; 71335-1533; 68788-7910; 52932-0726; 70934-515; 68071-4600; 68645-496; 47621-064; 0007-4140; 50090-2555; 0615-8018; 0093-7296; 63187-131; 68788-7883; 71335-2033; 68462-163; 71335-0561; 63187-946; 70786-0144; 42708-072; 0615-7946; 60760-235; 43353-832; 68788-7539; 55154-5676; 68071-4980; 76385-111; 50090-4171; 70934-910; 43063-833; 0615-8389; 61919-533; 53002-1574; 68084-854; 71610-132; 68788-7603; 50090-2119; 70518-0426; 68071-3078; 63629-4060; 51407-040; 55111-030; 53002-1573; 0781-5224; 0007-4141; 60760-233; 0904-6303; 76385-110; 70934-753; 68001-153; 60760-376; 68382-094; 70518-1826; 71335-2026; 70934-686; 0781-5221; 71335-1128; 0093-0051; 63187-447; 51407-042; 65862-369; 71335-1623; 53002-1556; 76385-112; 55111-254; 70934-211; 71610-062; 51079-932; 68071-2230; 50090-5115; 0378-3634; 50090-2066; 68382-093; 55154-6884; 68071-4974; 71335-1457; 68071-2633; 55700-819; 72888-034; 0615-7944; 71610-063; 0007-4142; 65841-619; 58118-0163; 0781-5223; 0378-3632; 68071-5275; 55154-5675; 66022-0120; 0007-4139; 55154-5677; 68788-7458; 71335-1937; 0378-3631; 0093-0135; 43063-129; 70934-516; 0615-7945; 62756-122; 55111-253; 71335-1463; 72888-035; 65841-616; 68788-9265; 70934-653; 68071-3269; 72888-036
Synonyms Carvedilol | Carvedilol Hydrochloride | Dilatrend | Querto | Eucardic | Carvedilol, (S)-isomer | Kredex | BM 14190 | BM-14190 | BM14190 | Carvedilol, (R)-isomer | Carvedilol, (+)-isomer | Carvedilol, (+) | Carvedilol, (+-)-isomer | Carvedilol, (-)-isomer | Carvedilol, (-) | Carvedilol, 14C-labeled | 14C-labeled Carvedilol | Carvedilol, 14C labeled | Coropres | Coreg
Chemical Information
Molecular Formula C24H26N2O4
CAS Registry Number 72956-09-3
SMILES COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 2D6P10635T57392Not Available
Adverse drug reactionCytochrome P450 2D6P10635T5739210772431; 15748098; 10983742
Atrioventricular block first degreeCytochrome P450 2D6P10635T57392Not Available
Atrioventricular block first degreeCytochrome P450 2D6P10635T5739210772431; 15748098; 10983742
Heart rate decreasedCytochrome P450 2D6P10635T57392Not Available
Heart rate decreasedCytochrome P450 2D6P10635T5739210772431; 15748098; 10983742
Left ventricular dysfunctionATP-dependent translocase ABCB1P08183T2525816800371; 12453548; 11738299
Vascular disordersMitogen-activated protein kinase 1P28482T5897026327764
Vascular disordersProto-oncogene tyrosine-protein kinase SrcP12931T8594326327764
Vascular disordersVascular endothelial growth factor receptor 2P35968T8097526327764
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dizziness postural02.01.02.005; 24.06.02.008; 17.02.05.0040.000492%Not Available
Drug abuse19.07.02.0100.000154%Not Available
Drug level increased13.17.01.004--Not Available
Drug withdrawal syndrome19.07.02.011; 08.06.02.004--Not Available
Dry mouth07.06.01.0020.000148%
Dyspepsia07.01.02.001--
Dysphagia07.01.06.0030.000197%
Dysphonia17.02.08.004; 22.02.05.005; 19.19.03.0020.000197%
Dyspnoea22.02.01.004; 02.01.03.0020.001574%
Eczema23.03.04.0060.000098%
Electrocardiogram QT prolonged13.14.05.0040.000295%
Embolism arterial24.01.01.0140.000148%
Epistaxis24.07.01.005; 22.04.03.0010.000246%
Erythema multiforme23.03.01.003; 10.01.03.015--
Extrasystoles02.03.02.003--Not Available
Face oedema08.01.07.003; 23.04.01.004; 10.01.05.0020.000148%
Fatigue08.01.01.002--
Feeling abnormal08.01.09.0140.000246%Not Available
Feeling cold08.01.09.008--Not Available
Flatulence07.01.04.002--
Fluid overload14.05.06.001; 02.05.04.004--Not Available
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.0250.000197%
Gamma-glutamyltransferase increased13.03.01.011--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Gastrointestinal pain07.01.05.005--
Generalised oedema14.05.06.007; 08.01.07.004--
Glucose tolerance impaired14.06.02.001; 05.06.02.001--
Glycosuria20.02.01.005--
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 12 Pages